Notice of Proposed Sale · 144
Takeda Pharmaceutical Co Ltd
TKPHFOTCEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Takeda Pharmaceutical Company Limited
- Issuer CIK
- 0001395064
- Phone
- 81-3-3278-2111
- Person for whose account securities are to be sold
- Rhonda Pacheco
- Relationships to issuer
- President, US Business Unit and US Country Head
- Street
- 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku
- City
- Tokyo
- State / country code
- M0
- Postal code
- 103-8668
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| American Depositary Shares (ADSs) | 18,316 | 306,789.1 | 143,310,556 | 07/13/2026 | NYSE | Interactive Brokers LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Interactive Brokers LLC
- Street
- One Pickwick Plaza
- City
- Greenwich
- State / country code
- CT
- Postal code
- 06830
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| ADSs | 07/01/2026 | Restricted Stock Unit Awards - Vested. | Takeda Pharmaceutical Company Limited | 50,582 | N | 07/01/2026 | Compensation |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 07/13/2026
- Signed
- /s/ Kate Huleatt, by power of attorney, for Rhonda Pacheco
Filed exhibits
- EX-24 ↗pacheco_section16andform14.pdf